COMP <GO>
REZI vs TMO // RSI-14 & 200D SMA MOMENTUM
Resideo Technologies Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: REZI 2
— TMO 8
▲ RSI-14 & 200D SMA MOMENTUM LEADER: TMO
LAST: $18.80 (+2.68%) • MKT CAP: $2.85B
rsi-technicals
60.6
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
rsi-technicals
62.9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (REZI VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | REZI | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 29.40% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.80% | 9.30% | -0.50 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 7.6x | 30.4x | -22.80 | REZI | /valuation <GO> |
| Free Cash Flow Yield | — | 2.40% | — | TIE | /fcf-yield <GO> |
| Operating Margin | 8.10% | 17.40% | -9.30 | TMO | /operating-margins <GO> |
| Net Profit Margin | -7.10% | 15.10% | -22.20 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 10.50% | 3.90% | +6.60 | REZI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.72 | 4.50 | -2.78 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 8/9 | -4.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 60.6 | 62.9 | -2.30 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 36.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.85B | $262.22B | -$259.36B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | REZI REV | TMO REV | REZI GROSS % | TMO GROSS % | REZI FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $7.47B | $44.56B | 29.4% | — | -$1.25B | $6.29B |
| FY 2024 | $6.76B | $42.88B | 28.1% | — | $364.0M | $7.27B |
| FY 2023 | $6.24B | $42.86B | — | — | $440.0M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
REZI // BETA —
TMO // BETA 0.94